PubRank

J A Zaia

Author PubWeight™ 84.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ribozymes as potential anti-HIV-1 therapeutic agents. Science 1990 4.49
2 Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother 1979 3.61
3 A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med 1991 3.05
4 Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis 1977 2.65
5 Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 1994 2.50
6 Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983 2.03
7 Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983 1.90
8 Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 1997 1.84
9 Direct detection of HIV-1 RNA from AIDS and ARC patient samples. DNA 1988 1.79
10 Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 1997 1.71
11 Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun 1978 1.60
12 Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994 1.56
13 Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis 1979 1.46
14 Airborne transmission of chickenpox in a hospital. N Engl J Med 1980 1.39
15 Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci U S A 1984 1.30
16 Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis 1983 1.24
17 Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation 1984 1.23
18 Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol 2011 1.23
19 CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993 1.14
20 Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 1994 1.13
21 Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 1997 1.10
22 A prospective analysis of nosocomial wound infection after mastectomy. Arch Surg 1983 1.09
23 Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus. J Virol 1984 1.07
24 Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988 1.05
25 Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis 1986 1.03
26 A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus. J Infect Dis 1981 1.01
27 Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 1994 1.00
28 Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group. J Acquir Immune Defic Syndr 1989 1.00
29 Human cytomegalovirus strain Towne pp65 gene: nucleotide sequence and expression in Escherichia coli. Virology 1991 0.99
30 Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems. AIDS Res Hum Retroviruses 1992 0.99
31 Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections. J Gen Virol 1984 0.95
32 Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther 2007 0.95
33 Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 1992 0.93
34 Infection of human peripheral blood mononuclear cells by varicella-zoster virus. Intervirology 1982 0.92
35 Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001 0.91
36 Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis 1996 0.91
37 Molecular and epidemiologic evaluations of a cluster of cases of Ménétrièr's disease associated with cytomegalovirus. Pediatr Infect Dis J 1993 0.87
38 Human cytomegalovirus strain Towne pp28 gene: sequence comparison to pp28 of HCMV AD169 and stable expression in Chinese hamster ovary cells. Virology 1991 0.87
39 A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector. Virology 2008 0.86
40 The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections. J Med Virol 1985 0.86
41 Hematologic Aspects of HIV/AIDS. Hematology Am Soc Hematol Educ Program 2001 0.86
42 Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients. J Clin Microbiol 1997 0.85
43 A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. J Immunol 1985 0.85
44 Immunosuppression and infection-progress. N Engl J Med 1977 0.84
45 Structural analysis of a 64-kDa major structural protein of human cytomegalovirus (Towne): identification of a phosphorylation site and comparison to pp65 of HCMV (AD169). Virology 1990 0.84
46 Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies. Transplantation 1986 0.83
47 Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting. Vaccine 2001 0.83
48 Quantitation of human cytomegalovirus DNA in lungs from bone marrow transplant recipients with interstitial pneumonia. J Infect Dis 1987 0.83
49 Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization. Scand J Immunol 2002 0.82
50 Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet 1988 0.81
51 Genomic localization of the gene encoding a 32-kDa capsid protein of human cytomegalovirus. Virology 1988 0.81
52 Ribozymes as therapies for AIDS. Ann N Y Acad Sci 1990 0.81
53 Altered gentamicin pharmacokinetics during the perioperative period. Clin Pharm 1985 0.81
54 Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus. J Infect Dis 1975 0.80
55 A chimeric tRNA(Lys3)-ribozyme inhibits HIV replication following virion assembly. Nucleic Acids Symp Ser 1995 0.80
56 Topical acyclovir treatment of herpes zoster in immunocompromised patients. J Am Acad Dermatol 1985 0.79
57 A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation. Biol Blood Marrow Transplant 1998 0.79
58 Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection. Antisense Nucleic Acid Drug Dev 1998 0.78
59 Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor. Blood 1997 0.78
60 Characterization of a 52K protein of murine cytomegalovirus and its immunological cross-reactivity with the DNA-binding protein ICP36 of human cytomegalovirus. J Gen Virol 1991 0.78
61 Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. J Infect Dis 2001 0.78
62 Brief report: nosocomial infection rates in a cancer treatment center. Infect Control 1984 0.78
63 Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein. Scand J Infect Dis Suppl 1995 0.78
64 Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood 1983 0.77
65 Differential detection of viral DNA and RNA in situ in cells infected with human cytomegalovirus. J Virol Methods 1989 0.77
66 Letter: Cellular immunity in multiple sclerosis. Lancet 1976 0.77
67 Genomic locus for a 140 kDa structural protein (pp150) of human cytomegalovirus in strains Towne and AD169. Virus Res 1989 0.77
68 The biology of human cytomegalovirus infection after bone marrow transplantation. Int J Cell Cloning 1986 0.76
69 Comparison of amphotropic and pseudotyped VSV-G retroviral transduction in human CD34+ peripheral blood progenitor cells from adult donors with HIV-1 infection or cancer. Exp Hematol 1998 0.76
70 Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors. Transplantation 1987 0.76
71 Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation. Transplantation 1984 0.76
72 Expression in insect cells and immune reactivity of a 28K tegument protein of human cytomegalovirus. J Gen Virol 1992 0.76
73 Altered expression of fibronectin gene in cells infected with human cytomegalovirus. J Virol 1990 0.76
74 Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older. J Clin Oncol 1986 0.75
75 Prospects for gene therapy using HIV-based vectors. Somat Cell Mol Genet 2001 0.75
76 Cytomegalovirus immune globulin: production from selected normal donor blood. Transplantation 1979 0.75
77 A practical method for preparation of varicella-zoster immune globulin. J Infect Dis 1978 0.75
78 Cytomegalovirus infection of the fetus and neonate. Neurol Clin 1984 0.75
79 Varicella vaccine. Pediatrics 1979 0.75